BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25376542)

  • 1. Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite.
    Zhong H; Deng X; Song Z; Darsow U; Chen W; Chen S; Luo N; Hao F
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1318-24. PubMed ID: 25376542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis.
    Lee J; Lee H; Noh S; Bae BG; Shin JU; Park CO; Lee KH
    Yonsei Med J; 2016 Mar; 57(2):393-8. PubMed ID: 26847292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-specific immunotherapy for patients with atopic dermatitis sensitized to animal dander.
    Chu H; Park KH; Kim SM; Lee JH; Park JW; Lee KH; Park CO
    Immun Inflamm Dis; 2020 Jun; 8(2):165-169. PubMed ID: 32162849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy.
    Kwon YS; Oh SH; Wu WH; Bae BG; Lee HJ; Lee MG; Lee KH
    Exp Dermatol; 2010 Mar; 19(3):246-51. PubMed ID: 19758316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen-specific immunotherapy for atopic eczema: updated.
    Darsow U
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):665-9. PubMed ID: 22918221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of allergen specific immunotherapy in atopic dermatitis patients in relation to quality of life.
    Wyrzykowska N; Czarnecka-Operacz M; Adamski Z
    Eur Ann Allergy Clin Immunol; 2015 Jan; 47(1):5-9. PubMed ID: 25599552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy Products.
    Park KH; Lee SC; Son YW; Jeong KY; Shin YS; Shin JU; Sim da W; Park HJ; Lee JH; Lee KH; Park JW
    Yonsei Med J; 2016 Nov; 57(6):1427-34. PubMed ID: 27593871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
    Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
    Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eczematous skin reaction to atopy patch testing with cockroach in patients with atopic dermatitis.
    Michel S; Yawalkar N; Schnyder B; Fischer B; Helbling A
    J Investig Allergol Clin Immunol; 2009; 19(3):173-9. PubMed ID: 19610259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the capacity of peripheral blood mononuclear cells to produce IL-4, IL-5 and IFN-gamma upon stimulation with house dust mite in children with atopic dermatitis.
    Kimura M; Yamaide A; Tsuruta S; Okafuji I; Yoshida T
    Int Arch Allergy Immunol; 2002 Mar; 127(3):191-7. PubMed ID: 11979044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis.
    Nahm DH; Kim ME; Kwon B; Cho SM; Ahn A
    Yonsei Med J; 2016 Nov; 57(6):1420-6. PubMed ID: 27593870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. House Dust Mites Confer a Distinct Immunological Feature among Dermatitis.
    Baris S; Ozen A; Akdeniz T; Karakoc-Aydiner E; Aydin O; Ercan H; Ogulur I; Camcioglu Y; Cengizlier R; Demirkesen C; Yucelten D; Demirel G; Barlan IB
    Iran J Allergy Asthma Immunol; 2016 Aug; 15(4):264-274. PubMed ID: 27921406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Close Positive Correlation between the Lymphocyte Response to Hen Egg White and House Dust Mites in Infants with Atopic Dermatitis.
    Kimura M; Meguro T; Ito Y; Tokunaga F; Hashiguchi A; Seto S
    Int Arch Allergy Immunol; 2015; 166(3):161-9. PubMed ID: 25871965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effects induced by intramuscular administration of autologous total immunoglobulin G in patients with atopic dermatitis.
    Cho SM; Kim ME; Kwon B; Nahm DH
    Int Immunopharmacol; 2017 Nov; 52():1-6. PubMed ID: 28846886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis?
    Bussmann C; Böckenhoff A; Henke H; Werfel T; Novak N
    J Allergy Clin Immunol; 2006 Dec; 118(6):1292-8. PubMed ID: 17157659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens].
    Silny W; Czarnecka-Operacz M; Silny P
    Wiad Lek; 2005; 58(3-4):184-92. PubMed ID: 16119162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis.
    Kim ME; Kim JE; Sung JM; Lee JW; Choi GS; Nahm DH
    J Korean Med Sci; 2011 Sep; 26(9):1159-64. PubMed ID: 21935270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.